Literature DB >> 11787830

Long-term seropositivity against Echinococcus multilocularis in an epidemiological follow-up study in southwestern Germany (Römerstein).

B Jensen1, S Reuter, W Kratzer, K Naser, V Kächele, P Kimmig, P Kern.   

Abstract

BACKGROUND: Out of 2,560 participants in an epidemiological survey of alveolar echinococcosis (AE) performed in 1996 in southwestern Germany, 47 participants had tested seropositive in one of two crude antigen screening ELISAs and were inconspicuous on hepatic ultrasound. PATIENTS AND METHODS: Out of these 47 seroreactors, 36 attended a follow-up examination 30 months after the primary examination, including ultrasound and serology with various Echinococcus multilocularis-specific antigens.
RESULTS: No lesion suspicious for AE was detected in any participant. Serology showed only minor changes as compared to the earlier results.
CONCLUSION: Persistent seropositivity without detectable hepatic lesions could be interpreted as an early sign of sonographically not yet detectable AE, immunity to E. multilocularis or unspecific serological reactivity. For seropositive and clinically inconspicuous inhabitants of areas endemic for AE follow-up examinations at intervals of 2-3 years seem to be adequate.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11787830     DOI: 10.1007/s15010-001-1153-3

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  3 in total

Review 1.  Epidemiology, clinical manifestations and diagnosis of zoonotic cestode infections: an update.

Authors:  W Raether; H Hänel
Journal:  Parasitol Res       Date:  2003-09-16       Impact factor: 2.289

2.  Case Report: Molecular Identification of Larval Taenia martis Infection in the Pouch of Douglas.

Authors:  Andreas Mueller; Gerhard Förch; Jozef Zustin; Birgit Muntau; Gerlind Schuldt; Dennis Tappe
Journal:  Am J Trop Med Hyg       Date:  2020-09-17       Impact factor: 3.707

Review 3.  Emerging infections in animals--potential new zoonoses?

Authors:  Fernando Torres-Vélez; Corrie Brown
Journal:  Clin Lab Med       Date:  2004-09       Impact factor: 1.935

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.